The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

Clinical trial NCT04818983 · COMPLETED

Trial details

NCT number: NCT04818983
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Extensive Disease Small Cell Lung Cancer

Start date: 2021-04-07
Primary completion: 2023-02-03
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.